Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
This trial is designed to generate impactful data that demonstrates our ability to safely and efficiently deliver an oral GLP-1R agonist using a validated technology. Prof Carel le Roux References 1
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
Weight loss is never easy, but it shouldnt be impossible
Lundsgaard A-M, Fritzen AM, Kiens B
The new research published in April 2026 showed improved blood pressure and cholesterol markers in participants, but a dedicated cardiovascular outcomes trial with hard endpoints is still in progress
No significant safety complaints, contamination reports, or efficacy concerns were found in public records as of March 2026
Similar content being viewed by others Subjects Introduction Hyponatremia is the most common electrolyte imbalance encountered in clinical practice, affecting up to 1342% of hospitalized patients 1,2
US$ 22.46
US$ 27.47
US$ 21.24
US$ 29.85
